Chemstat
NDC 44911-0911, Glycerinum, Taraxacum Officinale, Phytolacca Decandra, Arsenicum Album, Bovista, Carbo Vegetabilis, Carboneum Sulphuratum, Coffea Cruda, Nitricum Acidum, Nux Vomica, Petroleum, Phosphoricum Acidum, Phosphorus, Sulphur, Acetylsalicylicum Acidum, Formalinum, Glonoinum, Insulinum (Human), Lithium Carbonicum, Terebinthina, Thyroidinum (Suis), Aceticum Acidum, Benzoicum Acidum, Benzyl Alcohol, Boricum Acidum, Chlorinum, Cortisone Aceticum, Eugenol, Folliculinum, Isopropyl Palmitate, Lacticum Acidum,, liquid, from Energique, Inc..
- Product NDC
- 44911-0911
- Status
- Listed
- Labeler
- Energique, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0911 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCERIN3 [hp_X]/mL
- TARAXACUM OFFICINALE3 [hp_X]/mL
- PHYTOLACCA AMERICANA ROOT6 [hp_X]/mL
- ARSENIC TRIOXIDE12 [hp_X]/mL
- LYCOPERDON UTRIFORME FRUITING BODY12 [hp_X]/mL
- ACTIVATED CHARCOAL12 [hp_X]/mL
- CARBON DISULFIDE12 [hp_X]/mL
- ARABICA COFFEE BEAN12 [hp_X]/mL
- NITRIC ACID12 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED12 [hp_X]/mL
- KEROSENE12 [hp_X]/mL
- PHOSPHORIC ACID12 [hp_X]/mL
- PHOSPHORUS12 [hp_X]/mL
- SULFUR12 [hp_X]/mL
- ASPIRIN12 [hp_X]/mL
- FORMALDEHYDE SOLUTION12 [hp_X]/mL
- NITROGLYCERIN12 [hp_X]/mL
- INSULIN HUMAN12 [hp_X]/mL
- LITHIUM CARBONATE12 [hp_X]/mL
- TURPENTINE OIL12 [hp_X]/mL
- THYROID12 [hp_X]/mL
- ACETIC ACID12 [hp_X]/mL
- BENZOIC ACID12 [hp_X]/mL
- BENZYL ALCOHOL12 [hp_X]/mL
- BORIC ACID12 [hp_X]/mL
- CHLORINE12 [hp_X]/mL
- CORTISONE ACETATE12 [hp_X]/mL
- EUGENOL12 [hp_X]/mL
- ESTRONE12 [hp_X]/mL
- ISOPROPYL PALMITATE12 [hp_X]/mL
- LACTIC ACID, DL-12 [hp_X]/mL
- PETROLATUM12 [hp_X]/mL
- PHENYLBUTAZONE12 [hp_Q]/mL
- LEAD12 [hp_X]/mL
- POTASSIUM SORBATE12 [hp_X]/mL
- RESORCINOL12 [hp_X]/mL
- SALICYLIC ACID12 [hp_X]/mL
- SORBITOL12 [hp_X]/mL
- STEARYL ALCOHOL12 [hp_X]/mL
- XYLITOL12 [hp_X]/mL
- CORTICOTROPIN15 [hp_C]/mL
Pharmacologic classes
Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Dietary Proteins [CS]; Glycerol [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Insulin [CS]; Insulin [EPC]; Mood Stabilizer [EPC]; Nitrate Vasodilator [EPC]; Nitrates [CS]; Nitrogen Binding Agent [EPC]; Non-Standardized Chemical Allergen [EPC]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Pediculicide [EPC]; Plant Proteins [CS]; Plant Proteins [CS]; Platelet Aggregation Inhibitor [EPC]; Seed Storage Proteins [CS]; Seed Storage Proteins [CS]; Standardized Chemical Allergen [EPC]; Vasodilation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 44911-0911-1 | 44911091101 | 30 mL in 1 BOTTLE, DROPPER (44911-0911-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 44911-0911 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0911 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 44911-0911. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.